{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.174","meta":{"versionId":"3","lastUpdated":"2015-09-10T01:00:03.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.174","version":"20150910","name":"Gefitinib","status":"active","date":"2015-09-10T01:00:03-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"349472","display":"gefitinib 250 MG Oral Tablet"},{"code":"358777","display":"gefitinib 250 MG"},{"code":"378629","display":"gefitinib Oral Tablet"},{"code":"402091","display":"gefitinib 250 MG Oral Tablet [Iressa]"},{"code":"402435","display":"gefitinib Oral Tablet [Iressa]"},{"code":"576099","display":"gefitinib 250 MG [Iressa]"}]}]}}